A 36
Pill imprint A 36 has been identified as Mirtazapine (orally disintegrating) 15 mg.
Mirtazapine is used in the treatment of depression; anxiety; insomnia; hot flashes; post traumatic stress disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy.
Mirtazapine 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Mirtazapine (orally disintegrating) Images
- Imprint:
-
A
36 - Strength:
- 15 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- mannitol
aspartame
crospovidone
magnesium stearate
silicon dioxide
microcrystalline cellulose
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0021
| NDC Code | Manufacturer / Repackager |
|---|---|
| 59762-1410 | Greenstone LLC |
Note: Inactive ingredients may vary.
More Mirtazapine (Orally Disintegrating) resources
- Mirtazapine (Wolters Kluwer)
- Mirtazapine Orally Disintegrating Tablets (Wolters Kluwer)
- mirtazapine (Cerner Multum)
- Remeron RD (Micromedex) - Includes Dosage Information
- mirtazapine (Micromedex) - Includes Dosage Information
- Mirtazapine (AHFS DI)
- Mirtazapine Orally Disintegrating Tablets (FDA)
- Mirtazapine Tablets (FDA)
- Remeron Tablets (FDA)
- Mirtazapine (Wolters Kluwer)


